prostate cancer Archives - Page 2 of 7

Andrew C. Peterson, MD

Sep 12, 2022

Urologist, Survivorship Care Surgeon

Duke University School of Medicine

Dr. Peterson received his medical degree from Dartmouth Medical School in 1995 and completed his urology residency at Madigan Army Medical Center in 2002. He subsequently completed an advanced fellowship in Reconstructive Urology at Duke University in 2003. He then returned to Madigan Army Medical Center where he served as the Chief of Reconstructive Urology and the director of the urology residency.

Dr. Peterson joined the faculty at Duke in 2010 and currently serves as the Vice Chief of Medical Operations, the Urology Residency Program Director and directs the “Reconstructive Urology and Genitourinary Cancer Survivorship Fellowship”.

His research interests include improving the care of cancer survivors and the prevention of genitourinary side effects from various medical, surgical and radiation therapies for cancer. His clinical interests include reconstructive urology and bladder dysfunction in men and women; urinary incontinence in men; reconstruction for urethral stricture and trauma; new bladder construction and urinary diversion; video urodynamic study with particular value to patients with bladder-emptying problems and bladder-outlet symptoms; care of prostate cancer survivors with respect to sexual function and urinary continence, and urethral stricture disease after treatment with surgery or radiation. He is specifically skilled in the multidisciplinary management of complex genitourinary problems including scar tissue (bladder neck contracture, ureteral stricture), fistulas, radiation cystitis, and voiding dysfunction often seen in survivors of genitourinary cancers. He offers advanced surgical care including urethroplasty, placement of the artificial urinary sphincter (AUS), penile prosthesis, male sling, repair of recto-urethral fistula, and ureteral reimplantation for stricture.

During his 23 years in the United States Army Dr. Peterson achieved the rank of Colonel retiring from the Army Reserves in 2014. He is a graduate of the Command and General Staff College, and has been awarded the Expert Field Medical Badge, the Meritorious Service Medal with 3 oak leaf clusters, and the Bronze Star. He currently serves on the review panel of multiple peer reviewed journals. He is an active member of the Society for Genitourinary Reconstructive Surgeons and the Society for Government Service Urologists as well as the American Urologic Association.

Return to Session Four

Jeremy Tonkin, MD

Sep 12, 2022

Associate Professor of Medicine in the Department of Surgery / Division of Urology

Howard University Hospital

Dr. Jeremy Tonkin is currently an Associate Professor of Medicine in the Department of Surgery/Division of Urology at Howard University in Washington D.C. A native of Kansas City, Dr. Tonkin graduated from the University of Missouri-Kansas City 6-year combined BA/MD program. He did his general surgery and urologic surgery training at the University of Oklahoma. He then completed at 2-year fellowship in reconstructive urology at Eastern Virginia Medical School in Norfolk, VA.

In addition to general urology, Dr. Tonkin’s practice has a special focus on reconstructive urology. This includes the treatment of erectile dysfunction, male incontinence, urethral stricture disease, Peyronie’s disease, fistula repair and cosmetic genital surgery. He also specializes in other aspects of men’s heath such as androgen replacement and BPH.

Return to Session

Heather H. Goltz, PhD, MSW

Sep 9, 2022

Interim Assistant Chair of Criminal Justice and Social Work & Professor

University of Houston-Downtown

Dr. Heather Honoré Goltz is an oncology social worker, health educator, and sex therapist with over 15 years of experience developing and implementing clinical and psychosocial interventions for patients, caregivers, and couples impacted by complex medical and behavioral health conditions. She has earned degrees in biology (BS, Northwestern State University), social work and curriculum/instruction (MSW and MEd, University of Houston), health education and public health (PhD and MPH-Epidemiology, Texas A&M University). She completed post-doctoral fellowships in health services research and urology from the Michael E. DeBakey VAMC and Baylor College of Medicine, respectively, prior to her course of study in the University of Michigan’s Sexual Health Certificate Program sex therapy track. Dr. Goltz is a long-term member of the American Association of Sexuality Educators, Counselors, and Therapists (AASECT), the Association of Oncology Social Work (AOSW), the American Public Health Association (APHA), and the National Association of Social Workers (NASW). She is the current Co-Chair of the Bladder Cancer Advocacy Network’s Survivorship Working Group and the current AOSW Education Director. Dr. Goltz has co-authored over 40 peer-reviewed articles and collaborated on $3 million in research grants funded by ACS, NIH, DOD, and VA, primarily focusing on genitourinary cancer survivorship, cancer disparities, and sexual health.

LinkedIn

Return to Session

Mr. Lee Moultrie

Sep 9, 2022

Prostate Cancer Survivor and PHEN Ambassador, Charleston, SC

Lee H. Moultrie II is formerly a community outreach coordinator for the Medical University of South Carolina College of Nursing, and the REACH Charleston and Georgetown Diabetes Coalition (www.musc.edu/reach). In these positions, he works to promote healthful living; and connect people with public and private resources that can help them fight disease and raise their awareness of risk factors. After retiring from the United States Air Force, Moultrie became increasingly active in promoting health and wellness awareness. He participates in several ongoing research and awareness projects, including US TOO’s Minority and Underserved Populations Prostate Cancer Awareness Program, Men’s Health Network, National Black Leadership Initiative on Cancer III, US TOO Prostate Cancer Support Groups and the South Carolina Cancer Disparities Community Network. In 2005, Moultrie participated in a national PBS video special called “A Lion in the House,” which helped educate the community about the impact of childhood cancer on families. In 2006, he co-authored an article in the August Journal of South Carolina Medical Association entitled “Prostate Cancer Disparities in South Carolina: Two Generations Talking from a Male’s Perspective.” Moultrie also serves on the Executive Committee of the statewide South Carolina Cancer Alliance; the Executive Board for the Noisette Foundation; Chairman of the 100 Black Men of Charleston, Inc. School Improvement Council; Chairman for North Charleston High School; Promoting Health and Wellness Vision Council of the Trident United Way; Charleston County Diabetes Coalition; American Legion Veteran’s Organization; Royal Baptist Church and the Brotherhood Association; and also on the National Health and Wellness committee of the 100 Black Men of America, Inc. Moultrie hosts a monthly health-related talk radio program, and he participated in the production of a video called “Clinical Trials Awareness at the Hollings Cancer Center of the Medical University of South Carolina to encourage African Americans to participate in clinical trials. He has participated in several educational television sessions about health throughout the state and is frequently quoted in the newspaper. He serves on a leadership committee with the Glaucoma Research Foundation’s Historically Black Colleges and Universities Glaucoma Awareness Initiative, United Negro College Fund committee in Charleston, legislative ambassador with the American Cancer Society, Toast Master and a member of the 50 Million Pound Challenge. A strong civil rights activist, Moultrie was nominated for the Jefferson Award for community service in 2007.

Return to Session

Lola A. Fashoyin-Aje, MD, MPH

Sep 9, 2022

Medical Oncologist and Deputy Director in the Division of Oncology

Food and Drug Administration (FDA)

Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Division Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Food and Drug Administration (FDA).

Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Center for Drug Evaluation and Research- Food and Drug Administration (FDA). In this role, she provides scientific and policy guidance and oversight to multidisciplinary teams reviewing drugs and biologics under development for the treatment of solid tumor malignancies (gastrointestinal, cutaneous, and sarcoma). Dr. Fashoyin-Aje is also an Associate Director at the FDA Oncology Center of Excellence at the FDA, leading scientific and policy initiatives to address disparities and other regulatory science issues in oncology drug development. Prior to joining the FDA, Dr. Fashoyin-Aje completed her undergraduate and graduate training at Columbia University and Yale University, respectively, and received her M.D. degree from the University of Rochester School of Medicine and Dentistry. She completed her training in internal medicine and medical oncology at Johns Hopkins.

Return to Session Three